Sun Pharma subsidiary raises Rs. 1000 crore through debentures

Sun Pharmaceutical Industries' wholly-owned subsidiary Sun Pharma Laboratories Ltd has raised Rupees one thousand crore by allotment of 10,000 unsecured redeemable non-convertible debentures of a face value of Rs.10 lakh each on private placement basis.

These debentures will be listed on BSE under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rs. 500 crore with a tenure of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rs. 500 crore with a tenure of 39 months.